Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to -$7.0 million.

  • Aspen Aerogels' Change in Receivables fell 30589.6% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.9 million, marking a year-over-year decrease of 17536.65%. This contributed to the annual value of $39.4 million for FY2024, which is 21354.37% up from last year.
  • Latest data reveals that Aspen Aerogels reported Change in Receivables of -$7.0 million as of Q3 2025, which was down 30589.6% from -$1.0 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Change in Receivables registered a high of $33.0 million during Q2 2024, and its lowest value of -$31.9 million during Q1 2025.
  • For the 5-year period, Aspen Aerogels' Change in Receivables averaged around $2.8 million, with its median value being -$642000.0 (2021).
  • In the last 5 years, Aspen Aerogels' Change in Receivables surged by 166728.86% in 2022 and then crashed by 34307.65% in 2023.
  • Aspen Aerogels' Change in Receivables (Quarter) stood at $1.7 million in 2021, then skyrocketed by 1667.29% to $30.3 million in 2022, then crashed by 48.6% to $15.6 million in 2023, then tumbled by 138.43% to -$6.0 million in 2024, then dropped by 17.29% to -$7.0 million in 2025.
  • Its last three reported values are -$7.0 million in Q3 2025, -$1.0 million for Q2 2025, and -$31.9 million during Q1 2025.